Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-062584
Filing Date
2012-11-14
Accepted
2012-11-14 16:21:30
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326320_10q.htm 10-Q 666912
2 EXHIBIT 31.1 v326320_ex31-1.htm EX-31.1 8013
3 EXHIBIT 31.2 v326320_ex31-2.htm EX-31.2 8079
4 EXHIBIT 32.1 v326320_ex32-1.htm EX-32.1 4838
5 EXHIBIT 32.2 v326320_ex32-2.htm EX-32.2 4990
  Complete submission text file 0001144204-12-062584.txt   3143812

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnsz-20120930.xml EX-101.INS 295969
7 XBRL TAXONOMY EXTENSION SCHEMA gnsz-20120930.xsd EX-101.SCH 28839
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnsz-20120930_cal.xml EX-101.CAL 22326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnsz-20120930_def.xml EX-101.DEF 126489
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnsz-20120930_lab.xml EX-101.LAB 230958
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnsz-20120930_pre.xml EX-101.PRE 154527
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
GENSPERA INC (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 333-153829 | Film No.: 121204859
SIC: 2834 Pharmaceutical Preparations